Improving Motorcycle Taxi Driver Visibility in Tanzania

NCT ID: NCT01733537

Last Updated: 2013-08-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-02-28

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether providing motorcycle taxi drivers with a free reflective fluorescent vest will result in increased use of reflective or fluorescent clothing compared to education about wearing reflective or fluorescent clothing alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Road traffic injuries are the 4th leading cause of death among individuals in the economically productive age group (age 15 to 59) in low and middle income countries. The Africa region currently has some of the world's highest traffic injury rates, with vulnerable road users, including motorcycle riders, bearing a disproportionate share of the injury burden.

Motorcycles are a rapidly growing form of transport in Africa, both for personal and commercial transportation. Conspicuity measures-factors that increase a motorcycle rider's visibility-for the prevention of motorcycle crash have been previously studied and found to be associated with a decreased risk of crash.

Motorcycle taxi drivers are a particularly high risk population for motorcycle crash as they operate a motorcycle for several hours a day. Reflective, fluorescent safety vests are a common article worn by motorcycle drivers in some locations; however, penetration of such clothing in Moshi is currently low. This study aims to increase use of reflective vests among commercial motorcycle drivers. We will test whether provision of a free reflective, fluorescent vest increases use of reflective, fluorescent clothing compared to education about wearing reflective, fluorescent clothing alone.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Accidents, Traffic

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

traffic accidents, motorcycle, injury, conspicuity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vest and Education

Motorcycle Taxi Drivers provided with a reflective, fluorescent vest and basic education about recommended measures to increase their visibility

Group Type EXPERIMENTAL

Free reflective, fluorescent vest

Intervention Type OTHER

Motorcycle taxi drivers in the intervention arm will receive a free reflective, fluorescent vest

Education

Intervention Type BEHAVIORAL

Both arms will receive brief, basic education about recommended measures to increase their visibility

Education Alone

Motorcycle Taxi Drivers provided with basic education about recommended measures to increase their visibility

Group Type OTHER

Education

Intervention Type BEHAVIORAL

Both arms will receive brief, basic education about recommended measures to increase their visibility

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Free reflective, fluorescent vest

Motorcycle taxi drivers in the intervention arm will receive a free reflective, fluorescent vest

Intervention Type OTHER

Education

Both arms will receive brief, basic education about recommended measures to increase their visibility

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* motorcycle riders who identify themselves as motorcycle taxi drivers
* individuals must work at least 2 days a week as a motorcycle taxi driver
* have a telephone number for ride solicitation
* have a license plate that is able to be recorded
* are at least 18 years old
* are willing to have us contact them in the future for repeat surveys

Exclusion Criteria

* motorcycle riders who do not meet the above criteria
* motorcycle riders who do not consent to participate
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kilimanjaro Christian Medical Centre, Tanzania

OTHER

Sponsor Role collaborator

Fogarty International Center of the National Institute of Health

NIH

Sponsor Role collaborator

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nathan M Thielman, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Duke University

Steven A Sumner, MD

Role: STUDY_DIRECTOR

Duke University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kilimanjaro Region, Tanzania

Kilimanjaro Region, Kilimanjaro, Tanzania

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Tanzania

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R25TW009337-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

Pro00034415

Identifier Type: -

Identifier Source: org_study_id